Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet

NCT01004614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Amlodipine
DRUG: Amlodipine
DRUG: Amlodipine
DRUG: Amlodipine

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.